Welcome to the Yantasee Lab

Our research program employs functionalized nanomaterials in medicine. We are a part of the Department of Biomedical Engineering (BME) at the Oregon Health & Science University (OHSU) School of Medicine. Our expertise is in the development of animal models of cancer, kidney disease, and metals-related diseases, as well as the development of engineered nanomaterials to diagnose, prevent, or treat such diseases.

Recent News

Aug 11, 2017: Yantasee lab in collaboration with PDX Pharmaceuticals, LLC was recently awarded a $325,000 Phase I SBIR grant from the National Center for Advancing Translational Sciences, entitled "Development of topical formulation of siRNA-nanoparticle for treating skin diseases", R43TR001906, from Aug 2017 to Aug 2018.

May 16, 2017:
 Yantasee lab in collaboration with Dr. Joe Gray and PDX Pharmaceuticals, LLC was recently awarded a $1.7M Fast-Track Phase I/II SBIR grant from the National Cancer Institute, entitled "Nanoparticle-based targeted co-delivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer", R44CA217534, from May 2017 to May 2020.